Search research articles
Contact Us
Filters
Showing results (21-30 of 198) with videos related to
Page
of 20
Sort By:
Gastroenterologie Clinique Et Biologique
|
October 8, 1998
[Hepatotoxicity of antituberculosis drugs: practical implications for monitoring]
F Durand, J Bernuau, D Pessayre
Biochemical Pharmacology
|
May 1, 1983
Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats
D Larrey, M Tinel, D Pessayre
Journal of Hepatology
|
January 1, 1997
Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation
B Fromenty, A Berson, D Pessayre
Gastroenterologie Clinique Et Biologique
|
January 1, 1991
[Calcium in hepatocytes: physiology and physiopathology]
M Claret, D Pessayre, S Erlinger
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1981
Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450
G Danan, V Descatoire, D Pessayre
La Nouvelle Presse Medicale
|
October 22, 1977
[Effects of hepato-biliary diseases on drug metabolism (author's transl)]
D Pessayre, H Allemand, J P Benhamou
La Nouvelle Presse Medicale
|
May 1, 1976
[Toxicity caused by so-called reactive metabolites of drugs]
D Pessayre, P Mazel, J P Benhamou
Gastroenterologie Clinique Et Biologique
|
March 1, 1983
[Hepatitis caused by diclofenac]
G Babany, D Pessayre, J P Benhamou
Archives Francaises Des Maladies De L'Appareil Digestif
|
July 1, 1976
[Hepatitis due to erythromycin propionate (author's transl)]
D Pessayre, C Marie, J P Benhamou
Gastroenterologie Clinique Et Biologique
|
June 1, 1985
[Genetic polymorphism of the hepatic metabolism of drugs]
D Larrey, D Pessayre, J P Benhamou
Page
of 20
Search research articles
Search
Showing results (21-30 of 198) with videos related to
Sort By:
Page
of 20
Gastroenterologie Clinique Et Biologique
|
October 8, 1998
[Hepatotoxicity of antituberculosis drugs: practical implications for monitoring]
F Durand, J Bernuau, D Pessayre
Biochemical Pharmacology
|
May 1, 1983
Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats
D Larrey, M Tinel, D Pessayre
Journal of Hepatology
|
January 1, 1997
Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation
B Fromenty, A Berson, D Pessayre
Gastroenterologie Clinique Et Biologique
|
January 1, 1991
[Calcium in hepatocytes: physiology and physiopathology]
M Claret, D Pessayre, S Erlinger
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1981
Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450
G Danan, V Descatoire, D Pessayre
La Nouvelle Presse Medicale
|
October 22, 1977
[Effects of hepato-biliary diseases on drug metabolism (author's transl)]
D Pessayre, H Allemand, J P Benhamou
La Nouvelle Presse Medicale
|
May 1, 1976
[Toxicity caused by so-called reactive metabolites of drugs]
D Pessayre, P Mazel, J P Benhamou
Gastroenterologie Clinique Et Biologique
|
March 1, 1983
[Hepatitis caused by diclofenac]
G Babany, D Pessayre, J P Benhamou
Archives Francaises Des Maladies De L'Appareil Digestif
|
July 1, 1976
[Hepatitis due to erythromycin propionate (author's transl)]
D Pessayre, C Marie, J P Benhamou
Gastroenterologie Clinique Et Biologique
|
June 1, 1985
[Genetic polymorphism of the hepatic metabolism of drugs]
D Larrey, D Pessayre, J P Benhamou
Page
of 20